Clinical Trial Update: A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders [Phase 2, Phase 3]

View source ↗

Summary

The completed Phase 2/3 trial evaluated 18F-AV-133 PET imaging for distinguishing Parkinson's disease from other movement disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease with Lewy Bodies
• Parkinsonism

Drugs mentioned

• [18F] AV-133 (AV-133)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Parkinson's Disease, Primary Parkinsonism | Phase 2, Phase 3 | Status: COMPLETED